In response to Australia’s approval of MDMA and psilocybin use in therapy AUSTRALIA, Feb. 7, 2023 /PRNewswire/ — ATMA Journey Centers Inc. (“ATMA”), Canada’s leading psychedelic-assisted therapy training provider, is […]
Read more
ATMA to Sponsor Catalyst Summit 2022, May 20-22
Read more
ATMA will use Filament’s proprietary botanical drug candidate for clinical trials
Read more
Hello,’Tis the season to sit back and reflect on the year behind us. To be with shorter days and spend time with […]
Read more
The program will support greater accessibility and affordability for clients and enable therapists to share data and experiences among colleagues to increase the efficiency and effectiveness of Psychedelic-assisted Therapy.
Read more
CATALYST Presents Foundation (“CATALYST”), an Alberta-based not-for-profit event company focused on advancing the psychedelic medicine movement in Canada, announced the second annual CATALYST Summit 2021, Canada’s largest conference in the psychedelic medicine arena.
Read moreDr. Bains is the first psychiatrist in Canada to conduct legal psilocybin-assisted therapy at a private Canadian facility under a Section 56 Exemption from Health Canada
Read more
BACK TO TOP